HK1046853A1 - Method and compositions for treating hepatocellular cancer - Google Patents
Method and compositions for treating hepatocellular cancerInfo
- Publication number
- HK1046853A1 HK1046853A1 HK02108331.9A HK02108331A HK1046853A1 HK 1046853 A1 HK1046853 A1 HK 1046853A1 HK 02108331 A HK02108331 A HK 02108331A HK 1046853 A1 HK1046853 A1 HK 1046853A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- hepatocellular cancer
- treating hepatocellular
- treating
- cancer
- Prior art date
Links
- 206010073071 hepatocellular carcinoma Diseases 0.000 title 1
- 208000014018 liver neoplasm Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46448—Cancer antigens from embryonic or fetal origin
- A61K39/464481—Alpha-feto protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/53—Liver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18196600P | 2000-02-10 | 2000-02-10 | |
US66025200A | 2000-09-12 | 2000-09-12 | |
US66250500A | 2000-09-14 | 2000-09-14 | |
PCT/US2001/004539 WO2001058922A2 (en) | 2000-02-10 | 2001-02-12 | Method and compositions for treating hepatocellular cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1046853A1 true HK1046853A1 (en) | 2003-01-30 |
Family
ID=27391498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02108331.9A HK1046853A1 (en) | 2000-02-10 | 2002-11-18 | Method and compositions for treating hepatocellular cancer |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1253930A4 (en) |
JP (1) | JP3876162B2 (en) |
KR (1) | KR100482920B1 (en) |
CN (1) | CN1255427C (en) |
AU (1) | AU2001238179A1 (en) |
HK (1) | HK1046853A1 (en) |
WO (1) | WO2001058922A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100985914B1 (en) * | 2006-12-13 | 2010-10-08 | 주식회사 바이오리더스 | Cell Surface Expression Vector for liver Cancer Specific Antigen Alpha-fetoprotein and Microorganism Transformed by Thereof |
WO2008113970A2 (en) * | 2007-03-16 | 2008-09-25 | Ucl Business Plc | Peptides |
KR100900742B1 (en) * | 2007-05-17 | 2009-06-08 | 크레아젠 주식회사 | Animal Models Carrying Tumors Expressing Human Liver Cancer-Specific Antigen and Method for Analyzing Prevention and Treatment Efficacy of Dendritic Cells-Derived Immunotherapeutics Using the Above |
US8541543B2 (en) * | 2007-11-20 | 2013-09-24 | Academia Sinica | Peptides specific for hepatocellular carcinoma cells and applications thereof |
KR20170132793A (en) * | 2015-04-03 | 2017-12-04 | 유레카 쎄라퓨틱스, 인코포레이티드 | Constructs targeting AFP peptide / MHC complexes and uses thereof |
CN113072636B (en) * | 2020-01-06 | 2024-05-28 | 香雪生命科学技术(广东)有限公司 | T cell receptor for identifying AFP and coding sequence thereof |
CN113321725B (en) * | 2020-02-28 | 2024-06-11 | 香雪生命科学技术(广东)有限公司 | T cell receptor for identifying AFP |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1226551B (en) * | 1988-07-29 | 1991-01-24 | Sclavo Spa | IMMUNOLOGICALLY ACTIVE SYNTHETIC PEPTIDE CAPABLE OF INDUCING THE PRODUCTION OF ANTIBODIES WITH HIGH SPECIFICITY TOWARDS ALPHA-PHETOPROTEIN AND THEIR USE IN THE DIAGNOSTIC FIELD |
CN1150030C (en) * | 1995-01-24 | 2004-05-19 | 马蒂尼克斯研究与发展公司 | Recombinant human alpha-fetoprotein and uses thereof |
EP0979239B1 (en) * | 1997-02-13 | 2006-10-18 | The Regents Of The University Of California | Prevention and treatment of hepatocellular cancer |
-
2001
- 2001-02-12 JP JP2001558069A patent/JP3876162B2/en not_active Expired - Fee Related
- 2001-02-12 AU AU2001238179A patent/AU2001238179A1/en not_active Abandoned
- 2001-02-12 KR KR10-2002-7010174A patent/KR100482920B1/en not_active IP Right Cessation
- 2001-02-12 CN CNB018047580A patent/CN1255427C/en not_active Expired - Fee Related
- 2001-02-12 WO PCT/US2001/004539 patent/WO2001058922A2/en not_active Application Discontinuation
- 2001-02-12 EP EP01910587A patent/EP1253930A4/en not_active Ceased
-
2002
- 2002-11-18 HK HK02108331.9A patent/HK1046853A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1255427C (en) | 2006-05-10 |
KR20020073203A (en) | 2002-09-19 |
WO2001058922A9 (en) | 2002-10-17 |
EP1253930A4 (en) | 2003-05-21 |
WO2001058922A2 (en) | 2001-08-16 |
EP1253930A2 (en) | 2002-11-06 |
WO2001058922A3 (en) | 2002-02-14 |
JP2003522195A (en) | 2003-07-22 |
JP3876162B2 (en) | 2007-01-31 |
CN1398187A (en) | 2003-02-19 |
AU2001238179A1 (en) | 2001-08-20 |
KR100482920B1 (en) | 2005-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4768301A (en) | Synergistic methods and compositions for treating cancer | |
AP2006003708A0 (en) | Methods and compositions for treating flavivirusesand pestiviruses | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
EP1446114A4 (en) | Compositions and methods for treating osteoporosis | |
HUP0201436A3 (en) | Methods and compositions for treating solid tumors | |
EP1438062A4 (en) | Methods and compositions for treating dermal lesions | |
AU2002219945A1 (en) | Composition and method for treating snoring | |
IL140989A0 (en) | Compositions and methods for treating osteoporosis and lowering cholesterol | |
GB0110288D0 (en) | Composition and treatment method | |
EP1468118A4 (en) | Methods and compositions for treating cancer | |
IL144517A0 (en) | Compositions and methods for treating cataracts | |
EP1572118A4 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
AU4163402A (en) | Composition and method | |
EP1351647A4 (en) | Compositions and methods for treating hyperpigmentation | |
AU2001294686A1 (en) | Composition and process for treating metals | |
IL124650A0 (en) | Methods and therapeutic compositions for treating cancer | |
PL368948A1 (en) | Process and composition for treating wood | |
EP1282411A4 (en) | Method of treating cancer | |
EP1253930A4 (en) | Method and compositions for treating hepatocellular cancer | |
GB0123898D0 (en) | Method for treating objects | |
GB0118883D0 (en) | Method for treating objects | |
EP1349548A4 (en) | Methods and compositions for treating periodontal disease | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
EP1261331A4 (en) | Method and compositions for treating fibrotic diseases | |
GB0122810D0 (en) | Method for treating objects |